Home Newsfeeds JP Morgan Maintains Overweight on Micron Technology, Lowers Price Target to $80

JP Morgan Maintains Overweight on Micron Technology, Lowers Price Target to $80

JP Morgan analyst Harlan Sur maintains Micron Technology (NASDAQ:MU) with a Overweight and lowers the price target from $96 to $80.

byBenzinga Newsdesk

July 1, 2022

1 minute read

JP Morgan analyst Harlan Sur maintains Micron Technology (NASDAQ:MU) with a Overweight and lowers the price target from $96 to $80.

Barrington Research Maintains Outperform on Carriage Servs, Lowers Price Target to $50

By Benzinga Newsdesk

October 7, 1:49 PM

Barrington Research analyst Alexander Paris maintains Carriage Servs (NYSE:CSV) with a Outperform and lowers the price target from $55 to $50.

CSV

News

15 Senators Demand Southwest CEO Answer Questions About Holiday Travel Meltdown By Feb. 2

By Bill Haddad

January 13, 11:03 AM

-Reuters

LUV

RBC Capital Downgrades Bausch Health Companies to Sector Perform, Lowers Price Target to $5

By Benzinga Newsdesk

July 29, 6:12 AM

RBC Capital analyst Douglas Miehm downgrades Bausch Health Companies (NYSE:BHC) from Outperform to Sector Perform and lowers the price target from $12 to $5.

BHC

Reported Late Tuesday, Pacific Biosciences Of California, Inc. Announces Pricing Of Upsized $175M Public Offering Of 17.5M Shares Of Common Stock At a Price Of $10/Share

By Benzinga Newsdesk

January 25, 2:00 AM

Pacific Biosciences of California, Inc. (NASDAQ:PACB) ("PacBio") today announced that it has priced its previously announced underwritten public offering of 17,500,000 shares of its common stock at a

PACB

JP Morgan Maintains Overweight on Micron Technology, Lowers Price Target to $80

Related Posts

Barrington Research Maintains Outperform on Carriage Servs, Lowers Price Target to $50

15 Senators Demand Southwest CEO Answer Questions About Holiday Travel Meltdown By Feb. 2

RBC Capital Downgrades Bausch Health Companies to Sector Perform, Lowers Price Target to $5

Reported Late Tuesday, Pacific Biosciences Of California, Inc. Announces Pricing Of Upsized $175M Public Offering Of 17.5M Shares Of Common Stock At a Price Of $10/Share